跳至主要内容
临床试验/JPRN-UMIN000018162
JPRN-UMIN000018162已完成2 期

Randomized phase II study of clinical effect of ghrelin administration for DCF with esophageal cancer patients - Randomized phase II study of clinical effect of ghrelin administration for DCF with esophageal cancer patients

Osaka University School of Medicine Gastroenterological Surgery0 个研究点目标入组 40 人开始时间: 2015年7月2日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

Blood acyl ghrelin, total ghrelin, and IGF-1 concentrations on day 4 were significantly higher in the ghrelin group. The renal dysfunction, serum creatinine and cystatin C levels, dose reduction, and delay in the initiation of the second cycle of chemotherapy were lower in the ghrelin group than in the control group. Serum creatinine levels were significantly correlated with serum IGF-1 levels.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients with severe co morbid conditions 2. other active malignancy 3. judged as inappropriate by physician-in-charge 4. combination with radiation therapy 5. lactation and pregnancy

研究者

发起方
Osaka University School of Medicine Gastroenterological Surgery

相似试验

Randomized phase II study of clinical effect of... | 临床试验